Matt Abernethy, CFO: Neurocrine Biosciences NBIX Sell · Filed 25/02/14

Trade details

Type: Insider sale
Amount: $140,945.22
Shares · price: 1,206 sh · $116.87 a share
Held after: 35,810 sh
Stock: Neurocrine Biosciences NBIX
Person: Matt AbernethyCFO
Trade date: 25/02/13
Filed: 25/02/14
Days to filing: 1 days

Sold 3.3% of holdings

Share of holding sold: 3.3%

Neurocrine Biosciences trades, last 26 weeks

What else happened in Neurocrine Biosciences around then

Filed or reported within 30 days of the trade day · 25/01/14~25/03/15

Matt Abernethy's recent trades

Matt AbernethyOfficer
Planned sale10b5-1 planNeurocrine Biosciences
Planned sale10b5-1 plan
Neurocrine Biosciences
NBIX
$361K
2,311 sh
$361K
Filed 09/14
Traded 09/14
Matt AbernethyCFO
Sell10b5-1 planNeurocrine Biosciences
Sell10b5-1 plan
Neurocrine Biosciences
NBIX
$158K
1,352 sh
$158K
Filed 25/02/14
Traded 25/02/13
C. Abernethy MatthewOfficer
Planned sale10b5-1 planNeurocrine Biosciences
Planned sale10b5-1 plan
Neurocrine Biosciences
NBIX
$158.4K
1,352 sh
$158.4K
Filed 25/02/13
Traded 25/02/13
C. Abernethy MatthewOfficer
Planned sale10b5-1 planNeurocrine Biosciences
Planned sale10b5-1 plan
Neurocrine Biosciences
NBIX
$141.3K
1,206 sh
$141.3K
Filed 25/02/13
Traded 25/02/13
Matt AbernethyCFO
Sell10b5-1 planNeurocrine Biosciences
Sell10b5-1 plan
Neurocrine Biosciences
NBIX
$115.9K
980 sh
$115.9K
Filed 25/02/12
Traded 25/02/10

Matt Abernethy, CFO — sold $140.9K of Neurocrine Biosciences NBIX · 3.3% of holdings · 10b5-1 plan | Whalegun